Navigation Links
Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
Date:12/20/2007

- Study Identifies Novel Biomarkers Displaying 90% Sensitivity in Breast

Cancer -

ST. LOUIS, Dec. 20 /PRNewswire/ -- Orion Genomics announced today the discovery and validation of the most frequent DNA alterations detected in breast cancer to date. The results of a genome-wide analysis of DNA methylation appeared in PLoS ONE. The study entitled, "Identification of Novel High-Frequency DNA Methylation Changes in Breast Cancer" found more than 50 novel biomarkers, which were subsequently validated in up to 230 independent patient samples.

"Our study identified novel biomarkers that were individually capable of distinguishing early stage ductal breast cancer from normal and benign breast tissue," commented Jared Ordway, Ph.D., Director of Research and Development at Orion Genomics. "We are very excited about the potential of these findings as these biomarkers may be critical in the development of molecular diagnostics for the early detection of breast cancer."

Researchers applied a patented microarray-based approach to map tumor associated changes in DNA methylation, alterations that can affect normal gene expression. A single locus associated with the GHSR gene was the most powerful biomarker in the study, with a clinical sensitivity of 90% and a specificity of 96% for infiltrating ductal breast carcinoma. In addition to identifying biomarkers that might aid in the detection of breast cancer, the research revealed insights into the molecular mechanism of tumor development, which may lead to advances in breast cancer treatment.

"Twelve of our more than fifty breast cancer biomarkers exceeded the highest sensitivity previously reported for the stratification of tumor and normal tissue," added Nathan D. Lakey, President and CEO of Orion Genomics. "These results validate our biomarker discovery platform and our product pipeline, which is focused on breast, lung and ovarian cancer diagnostics."

Abo
'/>"/>

SOURCE Orion Genomics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... HILL, N.C. , Dec. 19, 2014 /PRNewswire/ ... innovative consumer research and marketing communication tools are ... and globally competitive – consequently consumers, desires, preferences, ... In this environment, market research groups across all ... and marketing communication tools. However, the adoption of ...
(Date:12/19/2014)... , December 18, 2014 ... software application/module that is used to store, manipulate, ... RIS comprises a patient tracking and scheduling system, ... integration of RIS with HIS and other databases ... patient registration and patient scheduling, patient list management, ...
(Date:12/19/2014)... Calif. , Dec. 18, 2014  Sage ... new generation of equipment for the testing of ... release of the new Luminary™ Profiler, the industry,s ... light-based measurement in a cost-effective, portable unit. ... the specific needs of the cannabis industry, the ...
Breaking Medicine Technology:Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2
... announced today that TRAKnet Practice Management Software 2.0 is ... EHR on October 28th, 2010 by the Certification ... accordance with the applicable Eligible Provider certification criteria adopted ... 2011/2012 criteria support the Stage 1 meaningful use measures ...
... MedSolutions ( www.medsolutions.com ), a leading provider of medical ... Institute and the Office of Continuing Education at Tufts ... webinar designed to assist primary care physicians and pediatricians ... "Doing the Right Thing: Diagnostic Radiology, Radiation Risk, and ...
Cached Medicine Technology:BioMedix's TRAKnet Practice Management Software Receives ONC-ATCB 2011/2012 Certification 2BioMedix's TRAKnet Practice Management Software Receives ONC-ATCB 2011/2012 Certification 3BioMedix's TRAKnet Practice Management Software Receives ONC-ATCB 2011/2012 Certification 4MedSolutions Offers Free CME Credit Imaging Safety Webinar for Physicians 2MedSolutions Offers Free CME Credit Imaging Safety Webinar for Physicians 3
(Date:12/22/2014)... (PRWEB) December 22, 2014 Give a ... season, the gift of health and vitality. , For ... its three top-selling anti-aging formulas in special Holiday Wellness ... rush delivery. , Each bottle contains cutting-edge, proven ... that don't work as well as we age. ...
(Date:12/22/2014)... York NY (PRWEB) December 22, 2014 ... that a federal panel of judges has granted a ... in the U.S. District Court, Eastern District of ... issued an order on December 12 to transfer over ... in 22 districts to the Louisiana court for consolidation ...
(Date:12/22/2014)... Petersburg, FL (PRWEB) December 22, 2014 Christmas ... Sublime Beauty® has a fast and easy solution that will ... gift cards can be purchased from from $25 up to ... "We offer 100% customer satisfaction and a wide array of ... have no fees and no expiration dates. , Gift ...
(Date:12/22/2014)... Washington, DC (PRWEB) December 22, 2014 ... begins its year-long, professional development programs this month. ... LEAD, which focuses on nurse educators fast-tracked for ... for the Leadership Development Program for Simulation Educators, ... that specialized area of nursing education. , ...
(Date:12/21/2014)... December 22, 2014 Recently, BambooFlooringChina.com, a ... strand woven bamboo flooring collection , and launched a ... The promotion is valid until Jan. 30, 2015. , ... bamboo is the hardest bamboo flooring available today; it ... that of traditional teak hardwoods. Strand woven bamboo is ...
Breaking Medicine News(10 mins):Health News:You Still Have Time to Give the Gift of Health and Vitality to a Mature Loved One 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 2Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 3Health News:Panel Orders Xarelto Lawsuits Consolidated Into Multi-District Litigation Reports Alonso Krangle LLP 4Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:BambooFlooringChina.com Announced Its Durable Strand Woven Bamboo Flooring Collection 2
... The U.S. Preventive Services Task Force (USPSTF), updating its ... for men over the age of 75. More evidence ... benefit from screening. , Previously, the Task Force ... screening for all men, and found inconclusive evidence that ...
... Thessaloniki, Greece - August 4, 2008 - A recent ... demonstrated that Erythropoiesis-stimulating agents (ESAs), a widely used drug ... the survival of myeloma patients. In the study, 323 ... period in Greece from 1988 to 2007. The investigators ...
... hazards outweigh benefits, government task force reports , , MONDAY, ... a dim view of prostate cancer screenings at any ... over 75. , The over-75 rule "is much more ... using the prostate-screening antigen (PSA) test, said Dr. Michael ...
... Increases 36% to $16.9 Million ... Record ... 4 ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer and marketer ... the,second quarter ended June 28, 2008. Revenue for the quarter was ...
... LOS ALTOS, Calif., Aug. 4 InteKrin Therapeutics, ... development of,products for diabetes, metabolism and obesity today ... Series C venture financing for $18.25,million. The financing ... CA and,Managing Director David Lowe Ph.D. of Skyline ...
... Aug. 4 Susan Reichle, the U.S.,Agency for ... the mission director. The promotion took place this ... of office during a,brief ceremony., "Susan,s appreciation ... and the agency well in her new position," ...
Cached Medicine News:Health News:Treatment with anti-anemia drugs may not be safe for multiple myeloma patients 2Health News:New Guidelines Rule Out Prostate Screening for Men Over 75 2Health News:New Guidelines Rule Out Prostate Screening for Men Over 75 3Health News:New Guidelines Rule Out Prostate Screening for Men Over 75 4Health News:ATS Medical Announces Second Quarter Results 2Health News:ATS Medical Announces Second Quarter Results 3Health News:ATS Medical Announces Second Quarter Results 4Health News:ATS Medical Announces Second Quarter Results 5Health News:ATS Medical Announces Second Quarter Results 6Health News:ATS Medical Announces Second Quarter Results 7Health News:ATS Medical Announces Second Quarter Results 8Health News:ATS Medical Announces Second Quarter Results 9Health News:ATS Medical Announces Second Quarter Results 10Health News:InteKrin Therapeutics Announces $20 Million Series C Financing 2
Fulgurating Electrode, 3 F...
ACMI S-Series Cystourethroscope Systems: Precision instruments designed for superior optical recognition, accurate control, and exceptional durability during steam autoclave sterilization....
Used to obtain biopsy specimens from pathological lesions in the ureter, renal pelvis, infundibula, or calyces. Supplied sterile in peel-open packages. Intended for one-time use....
Inquire...
Medicine Products: